Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASOS Regulatory News (ASC)

Share Price Information for ASOS (ASC)

Share Price is delayed by 15 minutes
Get Live Data
277.00    4.50 (1.65%)
Bid:
276.00
Ask:
279.00
Spread: 3.00 (1.087%)
Market Cap: £331.43m
ASC Live PriceLast checked at - London Stock Exchange

Intraday ASOS Share Chart

Long Term Incentive Plan

30 Apr 2013 07:00

RNS Number : 5285D
ASOS PLC
30 April 2013
 



 

30 April 2013

 

ASOS plc (the "Company")

ASOS Long Term Incentive Plan ("ALTIP")

 

 

 

Background

 

The Company's 2012 Annual Report and the Report and Accounts for the five months ended 31 August 2012 stated that the Company would establish a new long-term incentive plan for Executive Directors and Senior Management (the "ALTIP"). The Company is pleased to announce that, following consultation with some of its major shareholders, the implementation of the ALTIP has now been finalised. 

 

The purpose of the ALTIP is to support the published strategy and business plan for the next three years by incentivising and retaining the wider ASOS senior management team. This team comprises a larger pool of participants when compared with the previous Management Incentive Plan, to reflect the strengthening of the management capabilities across all areas of the ASOS business over the last three years. The ALTIP has a performance period from 1 September 2012 to 31 August 2015 (the "Performance Period") and is measured on challenging earnings per share ("EPS") and total shareholder return ("TSR") targets which are aligned to the strategic plans of the Company and designed to ensure growth is delivered in a profitable way.

 

Structure of the ALTIP

 

Under the terms of the ALTIP, awards will be structured in one or both of two ways.

 

The structure used depends upon whether the participants in the ALTIP make an investment equivalent to the tax fair value of all or part of their respective awards.

 

Executive Directors are required to make a minimum investment of their own money of at least one third of the tax fair value of their award. Senior Management participants are invited to invest at their choosing, with a required minimum investment of one third of the tax fair value of their awards. All participants also have the opportunity to voluntarily increase the value of their investment up to 100% of the tax fair value of their award.

 

This upfront investment by the ALTIP participants is designed to strengthen the link between their personal interests and those of the Company and its shareholders, providing a strong incentive to achieve the plan's performance targets. In return, for that part of their award for which an investment is made, Capital Gains Tax (and potentially Entrepreneur's Relief) should be payable by a participant on any gain made at vesting, as the invested award is purchased at the tax fair value. However, these investments will be forfeited if the performance conditions of the ALTIP are not met.

 

The proportion of any participant's award that is not covered by an upfront investment will be granted as conventional nil-cost options ("Option Scheme awards"). Should a member of Senior Management choose not to make the minimum investment of one third of the tax fair value of their award, the base value of their award will be reduced by 25%, to recognise the significantly lower risk profile, whilst still providing a market-competitive award value.

 

At the end of the three year Performance Period on 31 August 2015, awards under the ALTIP will vest, subject to the achievement of the performance conditions (which are set out in more detail below), in two tranches: Option Scheme awards will vest on 31 October 2015 up to a maximum value of 50% of a participant's total award; and the investment, together with any remaining Option Scheme award, on 31 October 2016.

 

The base value of each participant's award will be calculated as a set multiple of salary (as at 1 September 2012, or on joining, if later) and there is a maximum benefit restriction imposed on each participant.

 

Given that maximum benefit restriction, the Company expects the maximum dilution to existing shareholders to be approximately 1.3 million Ordinary Shares (or c.1.5% of issued share capital as at 31 March 2013).

 

Performance targets

 

The extent to which an award will vest will depend on interdependent EPS and relative TSR performance targets, measured over the performance period from 1 September 2012 to 31 August 2015. While the performance targets will be tested separately, both hurdles must be achieved for the awards to vest.

 

There are three performance levels under the EPS performance target. The 'threshold' performance level, which delivers a 6.7% maximum vesting (subject to any scale back as a result of the TSR performance), will not be met unless the compound rate of growth in fully-diluted underlying EPS (before exceptional items, but after the cost of the ALTIP) equals 17% per annum over the three years ending 31 August 2015. This equates to fully-diluted EPS for the year to 31 August 2015 of 63.4p per share and implies sales of £0.9bn.

 

The 'target' performance level, which delivers a 70% maximum vesting (subject to any scale back as a result of the TSR performance), will not be met unless the compound rate of growth in fully-diluted underlying EPS (before exceptional items, but after the cost of the ALTIP) equals 23% per annum over the same period. This equates to fully-diluted EPS for the year to 31 August 2015 of 73.7p per share and implies sales of £1.0bn, providing direct alignment with our previously communicated strategy.

 

The 'stretch' performance threshold, which delivers a 100% maximum vesting (subject to any scale back as a result of the TSR performance), will not be met unless the compound rate of growth in fully-diluted underlying EPS (before exceptional items, but after the cost of the ALTIP) equals or exceeds 32% per annum over the same period. This equates to fully-diluted EPS for the year to 31 August 2015 of 91.1p per share and implies sales of £1.3bn.

 

The TSR performance condition requires the comparison of TSR on an investment in ASOS with TSR on a notional investment in a comparator group during the Performance Period. The comparator group comprises all of the companies in the FTSE All Share General Retailers Index, as constituted at the commencement of the Performance Period, plus Mulberry plc. The TSR performance will be applied to the outturn from the EPS performance condition and may scale back (potentially to zero) whatever would have vested solely under the EPS condition. There will no scale back to the EPS outturn if the TSR of ASOS is at the upper quartile or above. The award will be scaled back progressively in the event that the TSR of ASOS is below upper quartile, such that there will be a scale back of up to one third if ASOS's TSR is at median. There will be zero vesting if ASOS's TSR is below median.

 

Other incentive awards

 

Whilst participants of the ALTIP will not receive any awards under the Company's existing Performance Share Plan ("PSP") during the performance period of the ALTIP, the Company will ensure that all other employees are able to share in the continued success of ASOS by continuing to make grants under the PSP and Share Incentive plan ("SIP"), which offers a grant of free shares to all eligible employees.

 

Share ownership guidelines

 

To align further the interests of Executive Directors with those of the Company's shareholders, the ALTIP is also intended to be a mechanism to encourage Executive Directors to build and maintain a significant shareholding in the business. Accordingly shareholding guidelines have been introduced requiring Executive Directors to retain 50% of any shares acquired on vesting of the ALTIP and any subsequent share awards thereafter (net of tax) until the following shareholdings are achieved:

 

·; CEO: 5 x salary

·; Executive Directors: 2 x salary

 

 

 

 

For further information:

 

ASOS plc

Nick Robertson, Chief Executive Officer

Tel: 020 7756 1000

Nick Beighton, Chief Finance Officer

Greg Feehely, Head of Investor Relations

 

College Hill

Matthew Smallwood/Justine Warren/Jamie Ramsay

Tel: 020 7457 2020

 

 

JPMorgan Cazenove 

Luke Bordewich / Gina Gibson

Tel: 020 7742 4000

 

 

Numis Securities

Alex Ham

Tel: 020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKCDPABKDFQB
Date   Source Headline
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
11th May 20267:00 amRNSDisposal of Lichfield fulfilment centre
1st May 202611:11 amRNSDirector/PDMR Shareholding
1st May 202611:07 amRNSAdmission of Shares and Total Voting Rights
28th Apr 202610:00 amRNSBlock Listing Application
24th Apr 202612:01 pmRNSDirector/PDMR Shareholding
24th Apr 202612:00 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSInterim results for the 26 weeks to 1 March 2026
15th Apr 202610:30 amRNSDirector Declaration
9th Apr 202612:44 pmRNSNotice of Results
25th Mar 20267:00 amRNSPre-close Trading Update
23rd Mar 202612:45 pmRNSHolding(s) in Company
13th Mar 202611:01 amRNSHolding(s) in Company
13th Mar 202611:00 amRNSHolding(s) in Company
13th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20265:00 pmRNSHolding(s) in Company
5th Feb 20265:00 pmRNSHolding(s) in Company
2nd Feb 20268:00 amRNSChange of Company Registrar
23rd Jan 20269:31 amRNSDirector/PDMR Shareholding
22nd Jan 20265:42 pmRNSResult of AGM
20th Jan 202611:07 amRNSDirector/PDMR Shareholding
14th Jan 202612:00 pmRNSDirector/PDMR Shareholding
5th Jan 202611:30 amRNSDirector/PDMR Shareholding
12th Dec 20255:00 pmRNSSAYE Scheme and Director/PDMR Dealing
8th Dec 20259:22 amRNSAnnual Financial Report
1st Dec 202511:00 amRNSTotal Voting Rights
25th Nov 20255:05 pmRNSDirector/PDMR Shareholding
24th Nov 20254:00 pmRNSHolding(s) in Company
21st Nov 20258:00 amRNSNon-Executive Director and Audit Chair Appointment
21st Nov 20257:00 amRNSFinal results for the 52 weeks to 31 August 2025
13th Nov 20257:00 amRNSNotice of Results & Confirmation of Board Changes
13th Nov 20257:00 amRNSASOS announces successful refinancing
10th Nov 20254:30 pmRNSBlock listing Interim Review
13th Oct 20253:00 pmRNSHolding(s) in Company
30th Sep 20257:00 amRNSFull Year Trading Update
31st Jul 20257:00 amRNSASOS announces Board changes
30th Jul 20255:30 pmRNSChange of Auditor
2nd Jul 20255:37 pmRNSDirector/PDMR Shareholding
17th Jun 20257:00 amRNSExecutive Director Change
12th May 20254:30 pmRNSBlock listing Interim Review
6th May 202512:05 pmRNSHolding(s) in Company
6th May 202512:00 pmRNSHolding(s) in Company
1st May 20259:30 amRNSTotal Voting Rights
24th Apr 20257:00 amRNSInterim results for the 26 weeks to 2 March 2025
21st Mar 20252:30 pmRNSHolding(s) in Company
21st Mar 20257:00 amRNSNotice of Results and Trading Update
19th Mar 20254:30 pmRNSHolding(s) in Company
13th Mar 20251:00 pmRNSHolding(s) in Company
6th Feb 202511:57 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.